Simon Jones

10.2k total citations
255 papers, 5.7k citations indexed

About

Simon Jones is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, Simon Jones has authored 255 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Physiology, 61 papers in Epidemiology and 59 papers in Rheumatology. Recurrent topics in Simon Jones's work include Lysosomal Storage Disorders Research (189 papers), Glycogen Storage Diseases and Myoclonus (54 papers) and Trypanosoma species research and implications (49 papers). Simon Jones is often cited by papers focused on Lysosomal Storage Disorders Research (189 papers), Glycogen Storage Diseases and Myoclonus (54 papers) and Trypanosoma species research and implications (49 papers). Simon Jones collaborates with scholars based in United Kingdom, United States and France. Simon Jones's co-authors include Robert Wynn, Paul Harmatz, Brian Bigger, Roberto Giugliani, Jean Mercer, J. E. Wraith, Christian J. Hendriksz, Barbara K. Burton, Rossella Parini and Frits A. Wijburg and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Simon Jones

241 papers receiving 5.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Jones United Kingdom 43 4.2k 1.7k 1.2k 969 656 255 5.7k
J. E. Wraith United Kingdom 37 4.2k 1.0× 1.9k 1.1× 1.3k 1.1× 573 0.6× 575 0.9× 84 5.0k
Christine M. Eng United States 34 2.7k 0.6× 1.3k 0.8× 984 0.8× 1.3k 1.4× 646 1.0× 81 5.7k
Michael Beck Germany 59 10.9k 2.6× 5.2k 3.2× 3.7k 2.9× 1.6k 1.7× 2.3k 3.5× 213 12.2k
John J. Mitchell United States 33 1.2k 0.3× 402 0.2× 575 0.5× 1.7k 1.8× 331 0.5× 131 4.2k
Flemming Skovby Denmark 39 613 0.1× 305 0.2× 1.5k 1.2× 2.0k 2.0× 210 0.3× 126 5.3k
David Chitayat Canada 55 706 0.2× 823 0.5× 577 0.5× 4.8k 4.9× 608 0.9× 403 11.6k
Wolfgang Grisold Austria 36 737 0.2× 1.3k 0.8× 221 0.2× 1.3k 1.3× 219 0.3× 217 8.5k
Chong Ae Kim Brazil 46 833 0.2× 671 0.4× 486 0.4× 4.0k 4.1× 494 0.8× 293 8.1k
Michael M. Kaback United States 35 1.1k 0.3× 389 0.2× 188 0.2× 1.5k 1.6× 302 0.5× 111 4.1k
Philippe Chanson France 72 887 0.2× 2.6k 1.6× 721 0.6× 2.7k 2.8× 235 0.4× 396 16.7k

Countries citing papers authored by Simon Jones

Since Specialization
Citations

This map shows the geographic impact of Simon Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Jones more than expected).

Fields of papers citing papers by Simon Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Jones. The network helps show where Simon Jones may publish in the future.

Co-authorship network of co-authors of Simon Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Jones. A scholar is included among the top collaborators of Simon Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Jones. Simon Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Reena, Simon Jones, Robert Wynn, et al.. (2025). Iron metabolism and hematological abnormalities in adult patients affected with mucopolysaccharidoses. Molecular Genetics and Metabolism Reports. 44. 101243–101243.
2.
Scarpa, Maurizio, George A. Díaz, Roberto Giugliani, et al.. (2025). Long‐Term Safety and Clinical Outcomes With Olipudase Alfa Enzyme Replacement Therapy in Children and Adolescents With Acid Sphingomyelinase Deficiency. Journal of Inherited Metabolic Disease. 48(5). e70086–e70086.
3.
Muenzer, Joseph, Barbara K. Burton, Paul Harmatz, et al.. (2024). Evaluation of early treatment with intravenous idursulfase and intrathecal idursulfase‐ IT on cognitive function in siblings with neuronopathic mucopolysaccharidosis II. Journal of Inherited Metabolic Disease. 48(3). e12790–e12790. 1 indexed citations
4.
Muenzer, Joseph, Carole Ho, Heather Lau, et al.. (2024). Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses. Molecular Genetics and Metabolism. 142(4). 108535–108535. 5 indexed citations
5.
Jones, Simon, David Cheillan, Anupam Chakrapani, et al.. (2023). Reply to Maase et al. Comment on “Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. Int. J. Neonatal Screen. 2022, 8, 20”. International Journal of Neonatal Screening. 9(1). 8–8. 1 indexed citations
6.
Muschol, Nicole, Roberto Giugliani, Simon Jones, et al.. (2022). Sanfilippo syndrome: consensus guidelines for clinical care. Orphanet Journal of Rare Diseases. 17(1). 391–391. 18 indexed citations
7.
Díaz, George A., Roberto Giugliani, Nathalie Guffon, et al.. (2022). Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results. Orphanet Journal of Rare Diseases. 17(1). 437–437. 28 indexed citations
8.
Brémovà-Ertl, Tatiana, Jens Claaßen, Jordi Gascón‐Bayarri, et al.. (2021). Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C. Journal of Neurology. 269(3). 1651–1662. 30 indexed citations
9.
Wijburg, Frits A., Stewart Rust, Jessica de Ruijter, et al.. (2021). Long-term safety and clinical outcomes of intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A. Molecular Genetics and Metabolism. 134(4). 317–322. 6 indexed citations
10.
Yılmaz, Berna Şeker, James Davison, Simon Jones, & Julien Baruteau. (2020). Novel therapies for mucopolysaccharidosis type III. Journal of Inherited Metabolic Disease. 44(1). 129–147. 28 indexed citations
11.
Griffiths, William J., Eylan Yutuc, Jonas Abdel‐Khalik, et al.. (2019). Metabolism of Non-Enzymatically Derived Oxysterols: Clues from sterol metabolic disorders. Free Radical Biology and Medicine. 144. 124–133. 34 indexed citations
12.
Clarke, L., Roberto Giugliani, Nathalie Guffon, et al.. (2019). Genotype‐phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry. Clinical Genetics. 96(4). 281–289. 51 indexed citations
13.
Harrison, Rebecca A., et al.. (2018). Transnasal adenoidectomy in mucopolysaccharidosis. International Journal of Pediatric Otorhinolaryngology. 111. 149–152. 5 indexed citations
14.
Wittkowski, Anja, et al.. (2018). Autism Spectrum Disorder symptomatology in children with Mucopolysaccharide Disease Type III. British Journal of Learning Disabilities. 47(1). 5–11. 5 indexed citations
15.
16.
Jones, Simon, Catherine Breen, Stewart Rust, et al.. (2016). A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA. Molecular Genetics and Metabolism. 118(3). 198–205. 83 indexed citations
17.
Mercer, Jean, et al.. (2016). Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I. The Journal of Pediatrics. 178. 219–226.e1. 38 indexed citations
18.
Nichani, Jaya, et al.. (2013). Feasibility of cochlear implantation in Mucopolysaccharidosis. International Journal of Pediatric Otorhinolaryngology. 77(8). 1255–1258. 6 indexed citations
19.
Jones, Simon, Rossella Parini, Paul Harmatz, et al.. (2013). The effect of idursulfase on growth in patients with Hunter syndrome: Data from the Hunter Outcome Survey (HOS). Molecular Genetics and Metabolism. 109(1). 41–48. 52 indexed citations
20.
Solanki, Guirish A., Tord D. Alden, Barbara K. Burton, et al.. (2012). A multinational, multidisciplinary consensus for the diagnosis and management of spinal cord compression among patients with mucopolysaccharidosis VI. Molecular Genetics and Metabolism. 107(1-2). 15–24. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. E. Wraith Breakdown of academic impact, for papers by Christine M. Eng Breakdown of academic impact, for papers by Michael Beck Breakdown of academic impact, for papers by John J. Mitchell Breakdown of academic impact, for papers by Flemming Skovby Breakdown of academic impact, for papers by David Chitayat Breakdown of academic impact, for papers by Wolfgang Grisold Breakdown of academic impact, for papers by Chong Ae Kim Breakdown of academic impact, for papers by Michael M. Kaback Breakdown of academic impact, for papers by Philippe Chanson
Rankless by CCL
2026